Strategy
Our strategy is designed with the intention to deliver a “functional” cure for OCD in our lifetime. To do that, we’re pursuing multiple projects across multiple disciplines simultaneously: Genetics, Neuroscience, and Therapeutics. We’re also building key infrastructure to facilitate real-time sharing of data and insights, and funding “moon shot” projects beyond our core focus.
Scientists
Our current team of core investigators includes leading scientists and physicians in the areas of genetics, neuroscience, psychiatry, and therapeutics. They have achieved breakthroughs in the fields of depression, autism, neuromodulation, and laboratory methods. They are leaders in their respective fields and their life’s work is essential to our strategy.
Seed Grants
Our current seed grants encompass a range of projects that include pilot studies of the potential therapeutic efficacy of novel interventions (e.g. tDCS) as well as preclinical studies of the functions of specific synaptic proteins implicated in OCD.